News List

Abbott, YRGCARE collaborate to track HIV, Hepatitis patterns


Abbott will provide study protocol and diagnostic equipment and YRGCARE will screen and sequence patient data from infected populations in India

By Team ABLE

Healthcare company Abbott and Chennai’s YR Gaitonde Centre for AIDS Research and Education have entered into a partnership to study the country’s viral diversity to improve the accuracy of diagnostic tests for HIV and Hepatitis.
Abbott will provide study protocol and diagnostic equipment and YRGCARE will screen and sequence patient data from infected populations in India, an Abbott note said.

According to Sunil Suhas Solomon, Chairman, YRGCARE, the drug using populations or PWIDs in India bear a disproportionate burden of HIV and HCV, and it was critical to understand the transmissions in this group. “Sequencing data in these affected populations will help us understand the evolutionary nature of the viruses enabling optimal treatment interventions to maximise impact,” he said.
Besides India, Abbott has collaborated with partners in China, Australia, Vietnam, Laos and Pakistan on similar surveillance programs.
Source: http://www.thehindubusinessline.com